Medical Drugs Equipment Supplied In California

Provides and meets the necessary stringent sanitary and cleanliness requirements for the food and beverage, pharmaceutical and biotech ...

The AOS Magellan Femoral Nail is targeted for use in intramedullary fixation of fractures of the femur. Its unique screw configuration provides both versatility and diversity for the Antegrade/ Retrograde Nail designs. Its innovative features offer superior solutions for the orthopedic advancement of hip fractures. ...

EpiFaith, a compact and robust device, assists physicians in locating the epidural space. Intuitively equipped with the Faith Signal visual indicator upon reaching the epidural space, EpiFaith® is beneficial to both junior and senior physicians by transforming the process into a safe and convenient procedure. ...

Stunner is the only system that pulls together UV/Vis concentration, Dynamic Light Scattering (DLS) and Static Light Scattering (SLS) data from the same 2 μL sample. Dig in to your AAV to get the total capsid titer and empty/full ratio, or rack up payload concentration and size data on any nanoparticle all at once. Nail down your protein quality by knocking concentration, hydrodynamic size, ...

Circumventing drug toxicity and drug resistance is key to effective anticancer therapy. Da Zen’s products and technologies deliver targeted anticancer drugs, such as simvastatin and cisplatin conjugated to a cancer targeting dye-carrier, exclusively to cancer cells, with the drugs confined to the cancer cells for much longer than current therapies (up to three to four weeks) and no evidence ...

AIVITA’s immunotherapy technology creates personalized vaccines for cancer patients that target and eliminate tumor-initiating cells which are the seed of the disease. Used alone or in parallel with other treatments, AIVITA’s cancer immunotherapy represents a powerful new approach in the search for curative treatments for ...

Opal is the first end-to-end integrated drug discovery & development platform. Traditional, linear approaches to target discovery and drug development have created sub-optimized systems that are intrinsically disintegrated and ...

Our proprietary COBRA SG drug-coated PTCA balloon includes a bio-active medical coating designed to improve adhesion of organic and inorganic substrates and optimize drug delivery. Developed at a leading, international medical university, the novel coating enables a unique and efficient excipient to carry a non-proliferative drug on the surface of PTCA balloons and has the flexibility to be ...

Xilis’ MicroOrganoSphereTM powers the only assay which can provide oncologists with accurate results of drug sensitivity on a patient’s own tumor within the clinical decision-making window - finally realizing the promise of precision medicine. Xilis is developing a panel of disease specific assays systematically testing the most important standard-of-care drugs within equipoise or ...

The skin is the body’s natural protective layer, with two primary barriers to passage: the stratum corneum on the surface and restrictive junctional proteins deeper in the skin. The stratum corneum is composed of flattened corneocytes set within a waxy, lipid matrix. This barrier is very effective at keeping water and nutrients inside the body and pathogens and chemicals out, making it the ...

Stem cell renewal and maintenance and tissue regeneration are critical for normal health and well-being. Wnt pathway interactions are crucial to maintenance of these processes. Ankasa is the first to produce human Wnt proteins in a manufacturing setting suitable for use in humans. Our first clinical approach will be the demonstration of improved outcomes after spinal fusion surgeries. Our product ...

CeloNova develops and manufactures novel surface coated technologies including its proprietary Polyzene-F nanocoating and COBRA SG Drug-Coated PTCA Balloon technology. This next-generation innovation is transforming clinical practice and promoting positive outcomes in patients around the ...

The product profile of SENTI-301 has the potential to promote expansion and persistence of NK cells, and activate and recruit the body’s own immune cells into the solid tumor microenvironment for enhanced anti-tumor activity. ...

We have proprietary printing technology and ink that allows for the sustained, continuous release of ophthalmic drugs via contact lenses and it is called the MediPrint process. Our unique process results in a novel way to for treat various eye diseases and conditions with a non-invasive, cost-effective treatment. We have an extensive global patent portfolio, comprising intellectual property ...

If your therapy is a particle, how do you tell a good one from a bad one? The Aura CL™ system couples Fluorescent Membrane Microscopy (FMM) and Backgrounded Membrane Imaging (BMI) to help you understand what’s in your cell therapy. It detects, counts, sizes, and IDs cellular aggregates and subvisible particles and ID’s cellular from other particles without any machine learning ...

Sirolimus is the most widely known mTOR inhibitor with a well-established safety and effectiveness profile in various treatment applications: Drug-eluting stents, Transplant, Oncology. Novolimus and Sirolimus have been studied as part of Elixir Medical’s Clinical Programs. These clinical trials for DynamX™, DESyne®, DESyne® BD and the fully resorbable DESolve® and ...

CAR-T cell therapies are a class of treatments in which T cells are modified to express chimeric antigen receptors (CARs). CARs are engineered molecules that, when present on the surface of a T cell, enable a T cell to recognize a specific protein that is present on the surface of other cells, including cancer cells. Upon recognition of the target cell via the CAR, the CAR-T cell kills the ...

T cells engineered with chimeric antigen receptors (CARs) have shown exceptional promise as a potentially curative therapy for patients with certain hematologic malignancies. While most researchers and clinical investigators continue to focus on the development of autologous or allogeneic CAR T-cell therapies, we are developing CAR NK cell product candidates created from clonal master engineered ...

CAR T-cell therapy has recently emerged as a revolutionary and potentially curative therapy for patients with certain hematologic malignancies, including refractory cancers. In 2017, two CAR T-cell therapies were approved by the FDA for the treatment of relapsed / refractory B-cell precursor acute lymphoblastic leukemia (ALL) and relapsed / refractory diffuse large B-cell lymphoma (DLBCL). While ...

Manuka Fill is Leptospermum scoparium Manuka honey from New Zealand. Our Manuka honey is fine filtered, rigorously tested and sterilized, making it appropriate for application to most wounds. Available in 1.5oz and 0.5oz tubes. Manuka Fill helps maintain a moist healing environment conducive to improving wound healing. ...